TRACON Pharmaceuticals Statistics

Total Valuation

TCON has a market cap or net worth of $1.69 million. The enterprise value is -$6.28 million.

Market Cap	1.69M
Enterprise Value	-6.28M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

TCON has 2.68 million shares outstanding. The number of shares has decreased by -89.92% in one year.

Shares Outstanding	2.68M
Shares Change (YoY)	-89.92%
Shares Change (QoQ)	-94.06%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	11.31%
Float	2.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.13
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	0.26
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.80

Current Ratio	0.80
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	1.05

Financial Efficiency

Return on equity (ROE) is -99.21% and return on invested capital (ROIC) is 693.02%.

Return on Equity (ROE)	-99.21%
Return on Assets (ROA)	18.69%
Return on Capital (ROIC)	693.02%
Revenue Per Employee	$714,412
Profits Per Employee	$102,824
Employee Count	17
Asset Turnover	1.05
Inventory Turnover	n/a

Taxes

Income Tax	-2.38M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.72% in the last 52 weeks. The beta is 1.28, so TCON's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	-89.72%
50-Day Moving Average	1.23
200-Day Moving Average	3.25
Relative Strength Index (RSI)	33.95
Average Volume (20 Days)	109,737

Short Selling Information

The latest short interest is 166,130, so 6.20% of the outstanding shares have been sold short.

Short Interest	166,130
Short Previous Month	118,982
Short % of Shares Out	6.20%
Short % of Float	6.34%
Short Ratio (days to cover)	0.95

Income Statement

In the last 12 months, TCON had revenue of $12.15 million and earned $1.75 million in profits.

Revenue	12.15M
Gross Profit	12.13M
Operating Income	-5.17M
Pretax Income	1.75M
Net Income	1.75M
EBITDA	-5.17M
EBIT	-5.19M
Earnings Per Share (EPS)	-$1.23

Full Income Statement

Balance Sheet

The company has $7.89 million in cash and no debt, giving a net cash position of $7.89 million or $2.95 per share.

Cash & Cash Equivalents	7.89M
Total Debt	n/a
Net Cash	7.89M
Net Cash Per Share	$2.95
Equity (Book Value)	-1.76M
Book Value Per Share	-0.66
Working Capital	-2.05M

Full Balance Sheet

Cash Flow

Operating Cash Flow	6.14M
Capital Expenditures	n/a
Free Cash Flow	6.14M
FCF Per Share	$2.57

Full Cash Flow Statement

Margins

Gross margin is 99.88%, with operating and profit margins of -42.59% and 14.39%.

Gross Margin	99.88%
Operating Margin	-42.59%
Pretax Margin	14.39%
Profit Margin	14.39%
EBITDA Margin	-42.53%
EBIT Margin	-42.72%
FCF Margin	50.52%

Dividends & Yields

TCON does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	89.92%
Shareholder Yield	89.92%
Earnings Yield	108.56%
FCF Yield	381.09%

Analyst Forecast

The average price target for TCON is $60.00, which is 9,408.72% higher than the current price. The consensus rating is "Hold".

Price Target	$60.00
Price Target Difference	9,408.72%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	59.88%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 10, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 10, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

TCON has an Altman Z-Score of -37.17 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-37.17
Piotroski F-Score	6